Long Term Comparative Effectiveness of Once Weekly Semaglutide Versus Standard of Care in a Real World Adult US Population With Type 2 Diabetes - a Randomized Pragmatic Clinical Trial
Phase of Trial: Phase IV
Latest Information Update: 09 Feb 2019
At a glance
- Drugs Semaglutide (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 23 Aug 2018 Planned End Date changed from 31 Dec 2021 to 19 Nov 2021.
- 23 Aug 2018 Planned primary completion date changed from 20 Nov 2019 to 20 Nov 2020.
- 23 Aug 2018 Status changed from not yet recruiting to recruiting.